Skip to Main ContentSkip to FooterSkip to Search

Advantages of Sourcing Biosimilars vs. Branded Biologics in Clinical Trials

Biosimilars can be used in place of a branded drug (if one exists), offering the sponsor a variety of benefits. But what is a biosimilar, exactly? Can a sponsor just replace the branded drug with the biosimilar, or are there certain requirements that need to be met in order to use it in a clinical trial?